Search Results

You are looking at 31 - 40 of 43 items for :

  • "kidney disease" x
Clear All
Full access

Kah Poh Loh, Ankit Kansagra, Meng-Shiou Shieh, Penelope Pekow, Peter Lindenauer, Mihaela Stefan and Tara Lagu

advance directives . Am J Kidney Dis 1993 ; 22 : 413 – 418 . 31. McAdoo SP Brown EA Chesser AM . Measuring the quality of end of life management in patients with advanced kidney disease: results from the pan-Thames renal audit group

Full access

George L. Jackson, Leah L. Zullig, S. Yousuf Zafar, Adam A. Powell, Diana L. Ordin, Ziad F. Gellad, David Abbott, James M. Schlosser, Janis Hersh and Dawn Provenzale

in part by a National Research Service Award-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) institutional training grant (T32 DK007568-17 to Duke University). Dr. Provenzale was funded in part by a K-24 career development

Full access

Thai H. Ho and Eric Jonasch

that are associated with ciliary dysfunction. Angiomyolipomas cause morbidity through spontaneous hemorrhage, invasion of adjacent renal parenchyma, and chronic kidney disease. The identification of mTORC1 activation caused by TSC1/2 mutations led to

Full access

Bradford R. Hirsch and Gary H. Lyman

-stage kidney disease on dialysis. After approval, 19 cases of hypersensitivity reactions and 3 deaths from the agent were reported. The reactions were more severe than those seen in the preapproval trials, leading the sponsors to voluntarily remove the agent

Full access

John Glaspy

Dixon J . Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease . Value Health 2008 ; 11 : 57 – 75 . 21 Casadevall N Nataf J

Full access

Daniel Boakye, Viola Walter, Lina Jansen, Uwe M. Martens, Jenny Chang-Claude, Michael Hoffmeister and Hermann Brenner

. Kazancioğlu R . Risk factors for chronic kidney disease: an update . Kidney Int Suppl (2011) 2013 ; 3 : 368 – 371 . 10.1038/kisup.2013.79 25019021 39. Kawai K , Sunami E , Yamaguchi H , . Nomograms for colorectal cancer: a systematic review

Full access

Supriya G. Mohile, Allison Magnuson, Chintan Pandya, Carla Velarde, Paul Duberstein, Arti Hurria, Kah Poh Loh, Megan Wells, Sandy Plumb, Nikesha Gilmore, Marie Flannery, Marsha Wittink, Ronald Epstein, Charles E. Heckler, Michelle Janelsins, Karen Mustian, Judith O. Hopkins, Jane Liu, Srihari Peri and William Dale

; 49 : 963 – 967 . 18. Campbell KH Smith SG Hemmerich J . Patient and provider determinants of nephrology referral in older adults with severe chronic kidney disease: a survey of provider decision making . BMC Nephrol 2011 ; 12 : 47

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven L. Hancock, Michael R. Harrison, Won Kim, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack, Bruce G. Redman, Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey Sosman, Mary Dwyer and Rashmi Kumar

. Partial nephrectomy has well-established oncologic outcomes data comparable to radical nephrectomy. 39 – 44 Radical nephrectomy can lead to an increased risk for chronic kidney disease 45 , 46 and is associated with increased risks of cardiovascular

Full access

Yuan-Yuan Lei, Suzanne C. Ho, Ashley Cheng, Carol Kwok, Chi-Kiu Iris Lee, Ka Li Cheung, Roselle Lee, Herbert H.F. Loong, Yi-Qian He and Winnie Yeo

, chronic liver disease, and chronic kidney disease. Anthropometric measurements included body weight, height, and waist and hip circumferences, which were measured according to standard protocols. Operationalization of the WCRF/AICR Recommendations

Full access

William G. Wierda, Andrew D. Zelenetz, Leo I. Gordon, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, John C. Byrd, Paolo Caimi, Luis E. Fayad, Richard I. Fisher, Martha J. Glenn, Thomas M. Habermann, Nancy Lee Harris, Francisco Hernandez-Ilizaliturri, Richard T. Hoppe, Steven M. Horwitz, Mark S. Kaminski, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Michael G. Martin, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Rachel Rabinovitch, Nishitha Reddy, Erin Reid, Kenneth Roberts, Ayman A. Saad, Erin D. Snyder, Lubomir Sokol, Lode J. Swinnen, Julie M. Vose, Joachim Yahalom, Mary A. Dwyer and Hema Sundar

0.88, 1.01, and 1.15 at 65, 70, and 75 years, respectively. In addition, approximately 44% of patients aged >65 years have some degree of chronic kidney disease, which also increases the likelihood of toxicity associated with fludarabine